Of relevance is the finding of these authors that CLL cells expressing on the surface high ROR1, an onco-embryonic orphan receptor, display increased p62/Nrf2-mediated antioxidant response and consequent resistance to pro-oxidative drugs such as venetoclax. Here, SQSTM1 is linked to B-cell chronic lymphocytic leukemia.